UBS Group’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-13,400
Closed -$3.3M 10572
2025
Q3
$3.3M Buy
+13,400
New +$2.7M ﹤0.01% 4464
2025
Q1
Sell
-25,000
Closed -$2.31M 10276
2024
Q4
$2.31M Buy
+25,000
New +$1.96M ﹤0.01% 4587

Other funds holding CLS

UBS Group's CLS Position: Q1 2026 in Review

UBS Group increased its Celestica (CLS) stake by 35% in Q1 2026, buying an estimated $32.9M and bringing the position to 435,306 shares worth $123M. The position accounts for 0.02% of the portfolio, ranked #901.

UBS Group first reported a position in CLS in Q4 2014 and has held it in 42 quarters since. 774 funds tracked by Wall St. Rank hold CLS as of Q1 2026.

  • UBS Group held 435,306 shares of Celestica worth $123M as of Q1 2026.
  • UBS Group bought 113,372 Celestica shares in Q1 2026, an estimated $32.9M.
  • Celestica made up 0.02% of UBS Group's portfolio in Q1 2026, its #901 holding.
  • UBS Group first reported a position in Celestica in Q4 2014 and has held it in 42 quarters since.
  • 774 funds tracked by Wall St. Rank held Celestica as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.